CRISPR Therapeutics
CRSP
CRSP
391 hedge funds and large institutions have $2.19B invested in CRISPR Therapeutics in 2025 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 121 increasing their positions, 101 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
8% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 60
2% less funds holding
Funds holding: 400 → 391 (-9)
14% less capital invested
Capital invested by funds: $2.54B → $2.19B (-$355M)
Holders
391
Holding in Top 10
6
Calls
$96.3M
Puts
$75.6M
Top Buyers
| 1 | +$43M | |
| 2 | +$40.6M | |
| 3 | +$30M | |
| 4 |
Morgan Stanley
New York
|
+$27.4M |
| 5 |
Two Sigma Advisers
New York
|
+$24.2M |
Top Sellers
| 1 | -$111M | |
| 2 | -$90.9M | |
| 3 | -$27.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$22.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21.1M |